89 results
Page 3 of 5
8-K
EX-4.1
09u5b wkn
16 Nov 20
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
w8vjd3 8cdqd
16 Nov 20
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
zvu 7loyn9on9jf5ml
18 Aug 20
Departure of Directors or Certain Officers
4:30pm
8-K
EX-4.1
acq rf9hz
31 Jul 20
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-10.1
zffs423fyu325vh
31 Jul 20
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-4.1
xbajx
6 Apr 20
Entry into a Material Definitive Agreement
5:06pm
8-K
EX-10.1
2ynitdrp
6 Apr 20
Entry into a Material Definitive Agreement
5:06pm
8-K
sguy6d
18 Dec 19
CytoDyn Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV
8:33am
8-K
EX-10.1
oc863jqkegt55py8r
30 Jan 19
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.1
1shnqx
30 Jan 19
Entry into a Material Definitive Agreement
5:00pm
8-K12G3
tzqo2gaxm
19 Nov 18
Notification of registration of securities
8:24am
8-K12G3
EX-4.1
6268dwn05rdl
19 Nov 18
Notification of registration of securities
8:24am
8-K12G3
EX-99.1
jmcvk1531
19 Nov 18
Notification of registration of securities
8:24am
8-K
EX-2.1
c5uq8dwxcif7
28 Aug 18
Entry into a Material Definitive Agreement
12:00am